Actively Recruiting
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Led by National Institute of Neurological Disorders and Stroke (NINDS) · Updated on 2026-05-05
700
Participants Needed
1
Research Sites
733 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objectives: The overall study objective is to compare the sensitivities and specificities of morphometric analysis techniques using structural MRI images based on pre- and postsurgical localization of epileptic foci in patients undergoing presurgical evaluation for medically refractory epilepsy. To carry out these analyses, we aim to establish an age-stratified normative imaging database using healthy volunteers. Additional objectives are to identify abnormal networks in these patients using resting state fMRI/EEG and MEG/EEG, and to use language and memory fMRI tasks to examine the effects of epileptogenic zones and surgery on cognitive function and the networks associated with these functions. Study population: 300 adults and children (age 8 and older) with uncontrolled focal epilepsy, and 200 age-stratified healthy volunteers. Design: A retrospective and prospective natural history study. Research procedures for patients in this study include neuropsychological testing and 1-4 MRI sessions during presurgical evaluation and an additional 1-3 MRI sessions and neuropsychological testing approximately 12 months post-operatively. Research testing (such as research neuropsychological tests or MRI scanning sequences) will be done during a visit for clinical testing whenever possible, likely reducing the number of required visits. Patients will also have optional MEG and 7T structural imaging. Data will also be obtained from patients who have already undergone epilepsy surgery if they had procedures as outlined in the protocol and are willing to share the data. Healthy volunteers will receive a subset of the pre-operative procedures for patients, requiring at least 3 visits. In order to ensure adequate data acquisition, subjects may be re-scanned up to three times for the portions of the study in which they participated, possibly requiring additional visits. Outcome measures: The main outcomes will be establishment of normative values for morphometric analysis methods in age-stratified normal controls, and comparison of the sensitivity and specificity of these measures to pre- and postsurgical localization of the epileptogenic zone. Secondary outcome measures will include determination of the sensitivity and specificity of source localization using MEG/EEG and resting state fMRI/EEG, and to evaluate changes in activation during rest, as well as language and memory fMRI tasks in patients pre- and postsurgically, to examine the effects of epileptogenic zones and surgery on cognitive function and the networks underlying these functions. ...
CONDITIONS
Official Title
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 8 and older
- Being evaluated or under evaluation for epilepsy surgery under protocol 18-N-0066, 11-N-0051, or 16-N-0041
- Documented focal epilepsy based on MRI, EEG, or seizure symptoms
- Ability to provide informed consent, or have a legally authorized representative or parent/guardian provide consent
- For patients solely contributing data: had epilepsy surgery with presurgical evaluation under protocol 18-N-0066 and a preoperative structural brain MRI as per protocol
- Healthy volunteers must be age 8 or older, able to give consent or have a parent/guardian consent, and able to undergo MRI without anesthesia
You will not qualify if you...
- Contraindications to MRI or MEG such as pacemakers, cochlear implants, shrapnel, or permanent eyeliner
- Claustrophobia or anxiety worsened by MRI
- Pregnancy; females of childbearing potential must have a negative pregnancy test before MRI
- For patients solely contributing data: inability or unwillingness to provide consent or lack of an appropriate surrogate
- For healthy volunteers: significant central nervous system medical conditions including psychiatric disorders, neurologic disorders, or active systemic diseases affecting the brain
- Use of centrally acting medications in the past 6 weeks including benzodiazepines, barbiturates, antidepressants, beta-blockers, or drugs for epilepsy or migraine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
A
Aaliyah M HamidullahThiam
CONTACT
S
Sara K Inati, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here